From: Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program
beta
E.S.
Signif.
HR
PFS
Myxoid LPS
−0.544
0.284
0.056
0.580
Line of treatment
0.272
0.117
0.020
1.312
OS
−0.970
0.241
0.000
0.379
Retroperitoneal STS
−0.524
0.209
0.012
0.592